Becton, Dickinson invests $34M in Connecticut syringe plant capacity
What happened
Becton, Dickinson and Company, a medical device maker based in New Jersey, invested over $34 million in its Canaan syringe manufacturing plant over the past five years. This investment added three production lines, increasing the plant's annual capacity by more than 50%. The facility now produces about 2.6 billion syringes annually and employs approximately 560 people.
From hartfordbusiness.com
Why it matters
The expansion supports U.S. domestic manufacturing, particularly following a 2024 increase in output after the U.S. Food and Drug Administration urged healthcare providers to move away from plastic syringes made in China. The investment also included funding for a health center in Connecticut.
From hartfordbusiness.com
Who's involved
- ConnecticutLocation of the manufacturing plant and recipient of health center funds.
- New JerseyHome state of Becton, Dickinson and Company.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- ConnecticutSpeculative
Connecticut could see increased job opportunities and manufacturing revenue due to the capacity expansion and local funding.
- ChinaSpeculative
China may see reduced demand for plastic syringes imported into the United States.
Keep exploring
The entities involved
-
Connecticut
state of the United States of America